nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC10—Doxorubicin—liver cancer	0.0817	0.121	CbGbCtD
Verapamil—ABCC4—Sorafenib—liver cancer	0.0647	0.0961	CbGbCtD
Verapamil—ABCC1—Epirubicin—liver cancer	0.0593	0.0881	CbGbCtD
Verapamil—ABCC3—Doxorubicin—liver cancer	0.0513	0.0763	CbGbCtD
Verapamil—ABCB11—Doxorubicin—liver cancer	0.0444	0.0659	CbGbCtD
Verapamil—ABCB11—bile canaliculus—liver cancer	0.0396	0.348	CbGeAlD
Verapamil—ABCC2—Sorafenib—liver cancer	0.0385	0.0571	CbGbCtD
Verapamil—ABCG2—Sorafenib—liver cancer	0.0348	0.0517	CbGbCtD
Verapamil—ABCC1—Doxorubicin—liver cancer	0.0315	0.0468	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0257	0.0382	CbGbCtD
Verapamil—CYP3A7—Sorafenib—liver cancer	0.0257	0.0382	CbGbCtD
Verapamil—CYP2B6—Sorafenib—liver cancer	0.0245	0.0363	CbGbCtD
Verapamil—ABCC2—Doxorubicin—liver cancer	0.0233	0.0347	CbGbCtD
Verapamil—ABCG2—Doxorubicin—liver cancer	0.0211	0.0313	CbGbCtD
Verapamil—ABCC2—bile canaliculus—liver cancer	0.0201	0.177	CbGeAlD
Verapamil—CYP3A5—Sorafenib—liver cancer	0.0193	0.0286	CbGbCtD
Verapamil—CYP2C8—Sorafenib—liver cancer	0.0185	0.0275	CbGbCtD
Verapamil—CYP2C19—Sorafenib—liver cancer	0.0155	0.0231	CbGbCtD
Verapamil—CYP2B6—Doxorubicin—liver cancer	0.0148	0.022	CbGbCtD
Verapamil—CYP1A2—Sorafenib—liver cancer	0.0143	0.0213	CbGbCtD
Verapamil—CYP2C9—Sorafenib—liver cancer	0.0129	0.0192	CbGbCtD
Verapamil—ABCB1—Sorafenib—liver cancer	0.0125	0.0186	CbGbCtD
Verapamil—ABCB11—bile duct—liver cancer	0.0124	0.109	CbGeAlD
Verapamil—CYP2D6—Sorafenib—liver cancer	0.0118	0.0176	CbGbCtD
Verapamil—ABCB11—bile—liver cancer	0.0095	0.0835	CbGeAlD
Verapamil—ABCC3—bile duct—liver cancer	0.00786	0.0691	CbGeAlD
Verapamil—ABCB1—Doxorubicin—liver cancer	0.00761	0.0113	CbGbCtD
Verapamil—CYP3A4—Sorafenib—liver cancer	0.00751	0.0112	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—liver cancer	0.00717	0.0107	CbGbCtD
Verapamil—ABCC2—bile duct—liver cancer	0.00628	0.0552	CbGeAlD
Verapamil—ABCC2—bile—liver cancer	0.00483	0.0424	CbGeAlD
Verapamil—CYP3A4—Doxorubicin—liver cancer	0.00456	0.00677	CbGbCtD
Verapamil—Hyperkeratosis—Sorafenib—liver cancer	0.0039	0.0735	CcSEcCtD
Verapamil—ABCC3—gall bladder—liver cancer	0.00168	0.0147	CbGeAlD
Verapamil—Gynaecomastia—Sorafenib—liver cancer	0.000997	0.0188	CcSEcCtD
Verapamil—Cardiac failure—Sorafenib—liver cancer	0.000828	0.0156	CcSEcCtD
Verapamil—CYP2C18—liver—liver cancer	0.000794	0.00698	CbGeAlD
Verapamil—ABCB11—liver—liver cancer	0.000773	0.00679	CbGeAlD
Verapamil—CYP3A7—liver—liver cancer	0.000756	0.00664	CbGeAlD
Verapamil—CACNA1H—liver—liver cancer	0.000709	0.00624	CbGeAlD
Verapamil—CACNB2—liver—liver cancer	0.00067	0.00589	CbGeAlD
Verapamil—Abdominal discomfort—Sorafenib—liver cancer	0.00067	0.0126	CcSEcCtD
Verapamil—Erectile dysfunction—Sorafenib—liver cancer	0.000644	0.0121	CcSEcCtD
Verapamil—CYP3A7-CYP3A51P—liver—liver cancer	0.000643	0.00565	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000618	0.0117	CcSEcCtD
Verapamil—Acute coronary syndrome—Sorafenib—liver cancer	0.000614	0.0116	CcSEcCtD
Verapamil—Myocardial infarction—Sorafenib—liver cancer	0.000611	0.0115	CcSEcCtD
Verapamil—Jaundice—Sorafenib—liver cancer	0.000607	0.0115	CcSEcCtD
Verapamil—Paralysis—Epirubicin—liver cancer	0.000592	0.0112	CcSEcCtD
Verapamil—CACNA1D—liver—liver cancer	0.000586	0.00515	CbGeAlD
Verapamil—Ileus—Epirubicin—liver cancer	0.000582	0.011	CcSEcCtD
Verapamil—Nystagmus—Epirubicin—liver cancer	0.000576	0.0109	CcSEcCtD
Verapamil—Paralysis—Doxorubicin—liver cancer	0.000548	0.0103	CcSEcCtD
Verapamil—Ileus—Doxorubicin—liver cancer	0.000538	0.0101	CcSEcCtD
Verapamil—Nystagmus—Doxorubicin—liver cancer	0.000533	0.0101	CcSEcCtD
Verapamil—Erythema multiforme—Sorafenib—liver cancer	0.000529	0.00997	CcSEcCtD
Verapamil—Tinnitus—Sorafenib—liver cancer	0.000522	0.00984	CcSEcCtD
Verapamil—Flushing—Sorafenib—liver cancer	0.000519	0.00979	CcSEcCtD
Verapamil—SLCO1B1—liver—liver cancer	0.000518	0.00456	CbGeAlD
Verapamil—Petechiae—Epirubicin—liver cancer	0.0005	0.00944	CcSEcCtD
Verapamil—Alopecia—Sorafenib—liver cancer	0.000494	0.00932	CcSEcCtD
Verapamil—ABCC3—liver—liver cancer	0.000492	0.00432	CbGeAlD
Verapamil—ABCC10—liver—liver cancer	0.000489	0.0043	CbGeAlD
Verapamil—Muscle spasms—Sorafenib—liver cancer	0.000468	0.00883	CcSEcCtD
Verapamil—Petechiae—Doxorubicin—liver cancer	0.000463	0.00873	CcSEcCtD
Verapamil—Angioedema—Sorafenib—liver cancer	0.000445	0.00839	CcSEcCtD
Verapamil—SLC22A1—liver—liver cancer	0.000438	0.00385	CbGeAlD
Verapamil—Syncope—Sorafenib—liver cancer	0.000437	0.00824	CcSEcCtD
Verapamil—Loss of consciousness—Sorafenib—liver cancer	0.000428	0.00807	CcSEcCtD
Verapamil—Atrioventricular block—Epirubicin—liver cancer	0.000424	0.008	CcSEcCtD
Verapamil—SLCO1A2—liver—liver cancer	0.000422	0.00371	CbGeAlD
Verapamil—Hypertension—Sorafenib—liver cancer	0.00042	0.00793	CcSEcCtD
Verapamil—Myalgia—Sorafenib—liver cancer	0.000415	0.00782	CcSEcCtD
Verapamil—Arthralgia—Sorafenib—liver cancer	0.000415	0.00782	CcSEcCtD
Verapamil—ABCC4—liver—liver cancer	0.000406	0.00357	CbGeAlD
Verapamil—Dry mouth—Sorafenib—liver cancer	0.000405	0.00765	CcSEcCtD
Verapamil—Anaphylactic shock—Sorafenib—liver cancer	0.000397	0.00749	CcSEcCtD
Verapamil—Infection—Sorafenib—liver cancer	0.000395	0.00745	CcSEcCtD
Verapamil—ABCC2—liver—liver cancer	0.000393	0.00345	CbGeAlD
Verapamil—Atrioventricular block—Doxorubicin—liver cancer	0.000393	0.00741	CcSEcCtD
Verapamil—Shock—Sorafenib—liver cancer	0.000391	0.00737	CcSEcCtD
Verapamil—Rash maculo-papular—Epirubicin—liver cancer	0.000374	0.00706	CcSEcCtD
Verapamil—Ecchymosis—Epirubicin—liver cancer	0.000372	0.00702	CcSEcCtD
Verapamil—Pulmonary oedema—Epirubicin—liver cancer	0.000366	0.00691	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000362	0.00683	CcSEcCtD
Verapamil—Dyspnoea—Sorafenib—liver cancer	0.000354	0.00668	CcSEcCtD
Verapamil—Dyspepsia—Sorafenib—liver cancer	0.00035	0.0066	CcSEcCtD
Verapamil—Rash maculo-papular—Doxorubicin—liver cancer	0.000346	0.00653	CcSEcCtD
Verapamil—ABCC1—liver—liver cancer	0.000346	0.00304	CbGeAlD
Verapamil—Ecchymosis—Doxorubicin—liver cancer	0.000344	0.00649	CcSEcCtD
Verapamil—Fatigue—Sorafenib—liver cancer	0.000343	0.00646	CcSEcCtD
Verapamil—Pain—Sorafenib—liver cancer	0.00034	0.00641	CcSEcCtD
Verapamil—Constipation—Sorafenib—liver cancer	0.00034	0.00641	CcSEcCtD
Verapamil—Pulmonary oedema—Doxorubicin—liver cancer	0.000339	0.00639	CcSEcCtD
Verapamil—CYP2C19—liver—liver cancer	0.000338	0.00297	CbGeAlD
Verapamil—Vascular purpura—Epirubicin—liver cancer	0.000334	0.0063	CcSEcCtD
Verapamil—Urticaria—Sorafenib—liver cancer	0.000316	0.00595	CcSEcCtD
Verapamil—Purpura—Epirubicin—liver cancer	0.00031	0.00585	CcSEcCtD
Verapamil—Vascular purpura—Doxorubicin—liver cancer	0.000309	0.00583	CcSEcCtD
Verapamil—Cardiac failure—Epirubicin—liver cancer	0.000306	0.00577	CcSEcCtD
Verapamil—ABCB1—embryo—liver cancer	0.000306	0.00269	CbGeAlD
Verapamil—Lethargy—Epirubicin—liver cancer	0.000305	0.00575	CcSEcCtD
Verapamil—Cerebrovascular accident—Epirubicin—liver cancer	0.000305	0.00575	CcSEcCtD
Verapamil—SLC22A5—liver—liver cancer	0.000304	0.00268	CbGeAlD
Verapamil—Diplopia—Epirubicin—liver cancer	0.000299	0.00564	CcSEcCtD
Verapamil—CYP2C8—liver—liver cancer	0.000295	0.00259	CbGeAlD
Verapamil—Hypersensitivity—Sorafenib—liver cancer	0.000293	0.00552	CcSEcCtD
Verapamil—Purpura—Doxorubicin—liver cancer	0.000287	0.00541	CcSEcCtD
Verapamil—ABCG2—liver—liver cancer	0.000287	0.00252	CbGeAlD
Verapamil—Asthenia—Sorafenib—liver cancer	0.000285	0.00538	CcSEcCtD
Verapamil—Cardiac arrest—Epirubicin—liver cancer	0.000284	0.00536	CcSEcCtD
Verapamil—Cardiac failure—Doxorubicin—liver cancer	0.000283	0.00534	CcSEcCtD
Verapamil—Lethargy—Doxorubicin—liver cancer	0.000282	0.00532	CcSEcCtD
Verapamil—Cerebrovascular accident—Doxorubicin—liver cancer	0.000282	0.00532	CcSEcCtD
Verapamil—Pruritus—Sorafenib—liver cancer	0.000281	0.0053	CcSEcCtD
Verapamil—Diplopia—Doxorubicin—liver cancer	0.000276	0.00521	CcSEcCtD
Verapamil—CYP1A2—liver—liver cancer	0.000276	0.00242	CbGeAlD
Verapamil—Orthostatic hypotension—Epirubicin—liver cancer	0.000273	0.00515	CcSEcCtD
Verapamil—Diarrhoea—Sorafenib—liver cancer	0.000272	0.00513	CcSEcCtD
Verapamil—CYP3A5—liver—liver cancer	0.000266	0.00234	CbGeAlD
Verapamil—CYP2B6—liver—liver cancer	0.000264	0.00232	CbGeAlD
Verapamil—Muscular weakness—Epirubicin—liver cancer	0.000264	0.00497	CcSEcCtD
Verapamil—Cardiac arrest—Doxorubicin—liver cancer	0.000263	0.00496	CcSEcCtD
Verapamil—Dizziness—Sorafenib—liver cancer	0.000263	0.00496	CcSEcCtD
Verapamil—CYP2C9—liver—liver cancer	0.000262	0.0023	CbGeAlD
Verapamil—Influenza—Epirubicin—liver cancer	0.000258	0.00487	CcSEcCtD
Verapamil—Vomiting—Sorafenib—liver cancer	0.000253	0.00477	CcSEcCtD
Verapamil—Orthostatic hypotension—Doxorubicin—liver cancer	0.000253	0.00476	CcSEcCtD
Verapamil—Angina pectoris—Epirubicin—liver cancer	0.000252	0.00474	CcSEcCtD
Verapamil—Rash—Sorafenib—liver cancer	0.000251	0.00473	CcSEcCtD
Verapamil—Dermatitis—Sorafenib—liver cancer	0.00025	0.00472	CcSEcCtD
Verapamil—Headache—Sorafenib—liver cancer	0.000249	0.0047	CcSEcCtD
Verapamil—Muscular weakness—Doxorubicin—liver cancer	0.000244	0.0046	CcSEcCtD
Verapamil—Upper respiratory tract infection—Epirubicin—liver cancer	0.00024	0.00453	CcSEcCtD
Verapamil—Influenza—Doxorubicin—liver cancer	0.000239	0.00451	CcSEcCtD
Verapamil—Pollakiuria—Epirubicin—liver cancer	0.000239	0.0045	CcSEcCtD
Verapamil—Nausea—Sorafenib—liver cancer	0.000236	0.00445	CcSEcCtD
Verapamil—Angina pectoris—Doxorubicin—liver cancer	0.000233	0.00439	CcSEcCtD
Verapamil—Drowsiness—Epirubicin—liver cancer	0.00023	0.00434	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000228	0.00431	CcSEcCtD
Verapamil—Jaundice—Epirubicin—liver cancer	0.000224	0.00423	CcSEcCtD
Verapamil—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000222	0.00419	CcSEcCtD
Verapamil—Sweating—Epirubicin—liver cancer	0.000221	0.00416	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—liver cancer	0.000221	0.00416	CcSEcCtD
Verapamil—Sinusitis—Epirubicin—liver cancer	0.000216	0.00407	CcSEcCtD
Verapamil—Drowsiness—Doxorubicin—liver cancer	0.000213	0.00402	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000211	0.00398	CcSEcCtD
Verapamil—Bradycardia—Epirubicin—liver cancer	0.00021	0.00397	CcSEcCtD
Verapamil—Jaundice—Doxorubicin—liver cancer	0.000208	0.00392	CcSEcCtD
Verapamil—Rhinitis—Epirubicin—liver cancer	0.000207	0.00391	CcSEcCtD
Verapamil—Hepatitis—Epirubicin—liver cancer	0.000207	0.0039	CcSEcCtD
Verapamil—Hypoaesthesia—Epirubicin—liver cancer	0.000206	0.00388	CcSEcCtD
Verapamil—Pharyngitis—Epirubicin—liver cancer	0.000205	0.00387	CcSEcCtD
Verapamil—Sweating—Doxorubicin—liver cancer	0.000204	0.00385	CcSEcCtD
Verapamil—Oedema peripheral—Epirubicin—liver cancer	0.000204	0.00384	CcSEcCtD
Verapamil—Sinusitis—Doxorubicin—liver cancer	0.0002	0.00377	CcSEcCtD
Verapamil—CYP3A4—liver—liver cancer	0.0002	0.00176	CbGeAlD
Verapamil—Visual impairment—Epirubicin—liver cancer	0.000199	0.00376	CcSEcCtD
Verapamil—CYP2D6—liver—liver cancer	0.000196	0.00173	CbGeAlD
Verapamil—Erythema multiforme—Epirubicin—liver cancer	0.000195	0.00369	CcSEcCtD
Verapamil—Bradycardia—Doxorubicin—liver cancer	0.000195	0.00367	CcSEcCtD
Verapamil—Tinnitus—Epirubicin—liver cancer	0.000193	0.00364	CcSEcCtD
Verapamil—Flushing—Epirubicin—liver cancer	0.000192	0.00362	CcSEcCtD
Verapamil—Rhinitis—Doxorubicin—liver cancer	0.000192	0.00362	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—liver cancer	0.000191	0.00361	CcSEcCtD
Verapamil—Hypoaesthesia—Doxorubicin—liver cancer	0.00019	0.00359	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—liver cancer	0.00019	0.00358	CcSEcCtD
Verapamil—Oedema peripheral—Doxorubicin—liver cancer	0.000188	0.00355	CcSEcCtD
Verapamil—Visual impairment—Doxorubicin—liver cancer	0.000184	0.00348	CcSEcCtD
Verapamil—Alopecia—Epirubicin—liver cancer	0.000183	0.00345	CcSEcCtD
Verapamil—Erythema multiforme—Doxorubicin—liver cancer	0.000181	0.00341	CcSEcCtD
Verapamil—Tinnitus—Doxorubicin—liver cancer	0.000178	0.00336	CcSEcCtD
Verapamil—Flushing—Doxorubicin—liver cancer	0.000178	0.00335	CcSEcCtD
Verapamil—Muscle spasms—Epirubicin—liver cancer	0.000173	0.00326	CcSEcCtD
Verapamil—Vision blurred—Epirubicin—liver cancer	0.00017	0.0032	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—liver cancer	0.000169	0.00319	CcSEcCtD
Verapamil—Agitation—Epirubicin—liver cancer	0.000165	0.00312	CcSEcCtD
Verapamil—Vertigo—Epirubicin—liver cancer	0.000162	0.00305	CcSEcCtD
Verapamil—Syncope—Epirubicin—liver cancer	0.000161	0.00304	CcSEcCtD
Verapamil—Muscle spasms—Doxorubicin—liver cancer	0.00016	0.00302	CcSEcCtD
Verapamil—Palpitations—Epirubicin—liver cancer	0.000159	0.003	CcSEcCtD
Verapamil—Loss of consciousness—Epirubicin—liver cancer	0.000158	0.00298	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—liver cancer	0.000157	0.00296	CcSEcCtD
Verapamil—Convulsion—Epirubicin—liver cancer	0.000156	0.00294	CcSEcCtD
Verapamil—Hypertension—Epirubicin—liver cancer	0.000155	0.00293	CcSEcCtD
Verapamil—Arthralgia—Epirubicin—liver cancer	0.000153	0.00289	CcSEcCtD
Verapamil—Chest pain—Epirubicin—liver cancer	0.000153	0.00289	CcSEcCtD
Verapamil—Myalgia—Epirubicin—liver cancer	0.000153	0.00289	CcSEcCtD
Verapamil—Agitation—Doxorubicin—liver cancer	0.000153	0.00289	CcSEcCtD
Verapamil—Discomfort—Epirubicin—liver cancer	0.000151	0.00285	CcSEcCtD
Verapamil—Dry mouth—Epirubicin—liver cancer	0.00015	0.00283	CcSEcCtD
Verapamil—Vertigo—Doxorubicin—liver cancer	0.00015	0.00282	CcSEcCtD
Verapamil—Syncope—Doxorubicin—liver cancer	0.000149	0.00282	CcSEcCtD
Verapamil—Confusional state—Epirubicin—liver cancer	0.000148	0.00279	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—liver cancer	0.000147	0.00278	CcSEcCtD
Verapamil—Anaphylactic shock—Epirubicin—liver cancer	0.000147	0.00277	CcSEcCtD
Verapamil—Oedema—Epirubicin—liver cancer	0.000147	0.00277	CcSEcCtD
Verapamil—Loss of consciousness—Doxorubicin—liver cancer	0.000146	0.00276	CcSEcCtD
Verapamil—Infection—Epirubicin—liver cancer	0.000146	0.00275	CcSEcCtD
Verapamil—Shock—Epirubicin—liver cancer	0.000144	0.00273	CcSEcCtD
Verapamil—Convulsion—Doxorubicin—liver cancer	0.000144	0.00272	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—liver cancer	0.000144	0.00271	CcSEcCtD
Verapamil—Tachycardia—Epirubicin—liver cancer	0.000143	0.0027	CcSEcCtD
Verapamil—Hyperhidrosis—Epirubicin—liver cancer	0.000142	0.00268	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—liver cancer	0.000142	0.00267	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—liver cancer	0.000142	0.00267	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—liver cancer	0.000142	0.00267	CcSEcCtD
Verapamil—ABCB1—liver—liver cancer	0.000141	0.00124	CbGeAlD
Verapamil—Discomfort—Doxorubicin—liver cancer	0.00014	0.00264	CcSEcCtD
Verapamil—Dry mouth—Doxorubicin—liver cancer	0.000139	0.00261	CcSEcCtD
Verapamil—Hypotension—Epirubicin—liver cancer	0.000137	0.00259	CcSEcCtD
Verapamil—Confusional state—Doxorubicin—liver cancer	0.000137	0.00258	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—liver cancer	0.000136	0.00256	CcSEcCtD
Verapamil—Oedema—Doxorubicin—liver cancer	0.000136	0.00256	CcSEcCtD
Verapamil—Infection—Doxorubicin—liver cancer	0.000135	0.00255	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000134	0.00252	CcSEcCtD
Verapamil—Shock—Doxorubicin—liver cancer	0.000134	0.00252	CcSEcCtD
Verapamil—Insomnia—Epirubicin—liver cancer	0.000133	0.00251	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—liver cancer	0.000133	0.0025	CcSEcCtD
Verapamil—Paraesthesia—Epirubicin—liver cancer	0.000132	0.00249	CcSEcCtD
Verapamil—Hyperhidrosis—Doxorubicin—liver cancer	0.000131	0.00248	CcSEcCtD
Verapamil—Dyspnoea—Epirubicin—liver cancer	0.000131	0.00247	CcSEcCtD
Verapamil—Somnolence—Epirubicin—liver cancer	0.000131	0.00246	CcSEcCtD
Verapamil—Dyspepsia—Epirubicin—liver cancer	0.000129	0.00244	CcSEcCtD
Verapamil—Hypotension—Doxorubicin—liver cancer	0.000127	0.00239	CcSEcCtD
Verapamil—Fatigue—Epirubicin—liver cancer	0.000127	0.00239	CcSEcCtD
Verapamil—Pain—Epirubicin—liver cancer	0.000126	0.00237	CcSEcCtD
Verapamil—Constipation—Epirubicin—liver cancer	0.000126	0.00237	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000124	0.00234	CcSEcCtD
Verapamil—Insomnia—Doxorubicin—liver cancer	0.000123	0.00232	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—liver cancer	0.000122	0.0023	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—liver cancer	0.000121	0.00228	CcSEcCtD
Verapamil—Feeling abnormal—Epirubicin—liver cancer	0.000121	0.00228	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—liver cancer	0.000121	0.00228	CcSEcCtD
Verapamil—Dyspepsia—Doxorubicin—liver cancer	0.00012	0.00226	CcSEcCtD
Verapamil—Fatigue—Doxorubicin—liver cancer	0.000117	0.00221	CcSEcCtD
Verapamil—Urticaria—Epirubicin—liver cancer	0.000117	0.0022	CcSEcCtD
Verapamil—Pain—Doxorubicin—liver cancer	0.000116	0.00219	CcSEcCtD
Verapamil—Constipation—Doxorubicin—liver cancer	0.000116	0.00219	CcSEcCtD
Verapamil—Feeling abnormal—Doxorubicin—liver cancer	0.000112	0.00211	CcSEcCtD
Verapamil—Hypersensitivity—Epirubicin—liver cancer	0.000108	0.00204	CcSEcCtD
Verapamil—Urticaria—Doxorubicin—liver cancer	0.000108	0.00204	CcSEcCtD
Verapamil—Asthenia—Epirubicin—liver cancer	0.000105	0.00199	CcSEcCtD
Verapamil—Pruritus—Epirubicin—liver cancer	0.000104	0.00196	CcSEcCtD
Verapamil—Diarrhoea—Epirubicin—liver cancer	0.0001	0.0019	CcSEcCtD
Verapamil—Hypersensitivity—Doxorubicin—liver cancer	0.0001	0.00189	CcSEcCtD
Verapamil—Asthenia—Doxorubicin—liver cancer	9.75e-05	0.00184	CcSEcCtD
Verapamil—Dizziness—Epirubicin—liver cancer	9.71e-05	0.00183	CcSEcCtD
Verapamil—Pruritus—Doxorubicin—liver cancer	9.61e-05	0.00181	CcSEcCtD
Verapamil—Vomiting—Epirubicin—liver cancer	9.34e-05	0.00176	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—liver cancer	9.3e-05	0.00175	CcSEcCtD
Verapamil—Rash—Epirubicin—liver cancer	9.26e-05	0.00175	CcSEcCtD
Verapamil—Dermatitis—Epirubicin—liver cancer	9.25e-05	0.00174	CcSEcCtD
Verapamil—Headache—Epirubicin—liver cancer	9.2e-05	0.00174	CcSEcCtD
Verapamil—Dizziness—Doxorubicin—liver cancer	8.99e-05	0.00169	CcSEcCtD
Verapamil—Nausea—Epirubicin—liver cancer	8.72e-05	0.00165	CcSEcCtD
Verapamil—Vomiting—Doxorubicin—liver cancer	8.64e-05	0.00163	CcSEcCtD
Verapamil—Rash—Doxorubicin—liver cancer	8.57e-05	0.00162	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—liver cancer	8.56e-05	0.00161	CcSEcCtD
Verapamil—Headache—Doxorubicin—liver cancer	8.51e-05	0.00161	CcSEcCtD
Verapamil—Nausea—Doxorubicin—liver cancer	8.07e-05	0.00152	CcSEcCtD
Verapamil—CYP2C19—Metabolism—PSMA4—liver cancer	5.86e-06	3.66e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PSMD10—liver cancer	5.86e-06	3.66e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSTP1—liver cancer	5.85e-06	3.65e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTA3—liver cancer	5.82e-06	3.63e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.82e-06	3.63e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—RAF1—liver cancer	5.8e-06	3.62e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—HMOX1—liver cancer	5.77e-06	3.6e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PSMA4—liver cancer	5.72e-06	3.57e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PSMD10—liver cancer	5.72e-06	3.57e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSTP1—liver cancer	5.72e-06	3.57e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GOT2—liver cancer	5.7e-06	3.56e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PPARG—liver cancer	5.68e-06	3.54e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MTOR—liver cancer	5.66e-06	3.53e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CB—liver cancer	5.66e-06	3.53e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—HMOX1—liver cancer	5.64e-06	3.52e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYCS—liver cancer	5.62e-06	3.51e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GOT2—liver cancer	5.57e-06	3.47e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GGT1—liver cancer	5.51e-06	3.44e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GOT1—liver cancer	5.51e-06	3.44e-05	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	5.46e-06	3.4e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CG—liver cancer	5.45e-06	3.4e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CD—liver cancer	5.44e-06	3.4e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.43e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CG—liver cancer	5.4e-06	3.37e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PSMA4—liver cancer	5.39e-06	3.36e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PSMD10—liver cancer	5.39e-06	3.36e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSTM1—liver cancer	5.38e-06	3.36e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ALB—liver cancer	5.37e-06	3.35e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP2E1—liver cancer	5.36e-06	3.35e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.36e-06	3.35e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PSMA4—liver cancer	5.34e-06	3.34e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PSMD10—liver cancer	5.34e-06	3.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTA4—liver cancer	5.32e-06	3.32e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CDKN1B—liver cancer	5.31e-06	3.32e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.28e-06	3.29e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CB—liver cancer	5.27e-06	3.29e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PPARG—liver cancer	5.26e-06	3.28e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSTM1—liver cancer	5.26e-06	3.28e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GOT2—liver cancer	5.24e-06	3.27e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP2E1—liver cancer	5.23e-06	3.27e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PPARG—liver cancer	5.21e-06	3.25e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GOT2—liver cancer	5.2e-06	3.24e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.19e-06	3.24e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTA2—liver cancer	5.19e-06	3.24e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CD—liver cancer	5.17e-06	3.23e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HPGDS—liver cancer	5.12e-06	3.2e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ALB—liver cancer	5.1e-06	3.19e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP1A1—liver cancer	5.1e-06	3.18e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.09e-06	3.18e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CG—liver cancer	5.02e-06	3.14e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CTNNB1—liver cancer	5.02e-06	3.13e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYCS—liver cancer	5.02e-06	3.13e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTA1—liver cancer	5e-06	3.12e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP1A1—liver cancer	4.98e-06	3.11e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTP1—liver cancer	4.95e-06	3.09e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PIK3CA—liver cancer	4.95e-06	3.09e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NAT2—liver cancer	4.95e-06	3.09e-05	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	4.93e-06	3.08e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP2E1—liver cancer	4.93e-06	3.08e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GOT1—liver cancer	4.92e-06	3.07e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GGT1—liver cancer	4.92e-06	3.07e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CDKN1A—liver cancer	4.9e-06	3.06e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYCS—liver cancer	4.9e-06	3.06e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP2E1—liver cancer	4.89e-06	3.05e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—HMOX1—liver cancer	4.88e-06	3.05e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PPARG—liver cancer	4.85e-06	3.03e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GOT1—liver cancer	4.8e-06	3e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GGT1—liver cancer	4.8e-06	3e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CD—liver cancer	4.79e-06	2.99e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—MTHFR—liver cancer	4.75e-06	2.97e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CD—liver cancer	4.75e-06	2.96e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CB—liver cancer	4.74e-06	2.96e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALDOB—liver cancer	4.74e-06	2.96e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.73e-06	2.95e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ALB—liver cancer	4.73e-06	2.95e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PIK3CA—liver cancer	4.72e-06	2.95e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PIK3CA—liver cancer	4.69e-06	2.92e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ALB—liver cancer	4.68e-06	2.92e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARA—liver cancer	4.66e-06	2.91e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—MTHFR—liver cancer	4.64e-06	2.9e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.64e-06	2.9e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYCS—liver cancer	4.61e-06	2.88e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.58e-06	2.86e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYCS—liver cancer	4.57e-06	2.85e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PSMA4—liver cancer	4.57e-06	2.85e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PSMD10—liver cancer	4.57e-06	2.85e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARA—liver cancer	4.56e-06	2.84e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTM1—liver cancer	4.55e-06	2.84e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GOT1—liver cancer	4.53e-06	2.83e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GGT1—liver cancer	4.53e-06	2.83e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CRABP1—liver cancer	4.52e-06	2.82e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CB—liver cancer	4.51e-06	2.81e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GOT1—liver cancer	4.49e-06	2.8e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GGT1—liver cancer	4.49e-06	2.8e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GOT2—liver cancer	4.44e-06	2.77e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTP1—liver cancer	4.42e-06	2.76e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CD—liver cancer	4.42e-06	2.76e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—STAT3—liver cancer	4.38e-06	2.73e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HMOX1—liver cancer	4.36e-06	2.72e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ALB—liver cancer	4.36e-06	2.72e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTP1—liver cancer	4.32e-06	2.69e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP1A1—liver cancer	4.31e-06	2.69e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HMOX1—liver cancer	4.26e-06	2.66e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP2E1—liver cancer	4.18e-06	2.61e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CB—liver cancer	4.17e-06	2.6e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CB—liver cancer	4.14e-06	2.58e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CA—liver cancer	4.12e-06	2.57e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—liver cancer	4.07e-06	2.54e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTP1—liver cancer	4.07e-06	2.54e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTM1—liver cancer	4.06e-06	2.54e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—TGFB1—liver cancer	4.06e-06	2.53e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.04e-06	2.52e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—liver cancer	4.04e-06	2.52e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTP1—liver cancer	4.03e-06	2.52e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—MTHFR—liver cancer	4.02e-06	2.51e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HMOX1—liver cancer	4.01e-06	2.5e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CG—liver cancer	3.99e-06	2.49e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HMOX1—liver cancer	3.98e-06	2.48e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTM1—liver cancer	3.97e-06	2.47e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HPGDS—liver cancer	3.95e-06	2.47e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARA—liver cancer	3.95e-06	2.46e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYCS—liver cancer	3.91e-06	2.44e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CG—liver cancer	3.9e-06	2.44e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—liver cancer	3.86e-06	2.41e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARG—liver cancer	3.85e-06	2.4e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP1A1—liver cancer	3.85e-06	2.4e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CB—liver cancer	3.85e-06	2.4e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CA—liver cancer	3.85e-06	2.4e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GGT1—liver cancer	3.84e-06	2.39e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GOT1—liver cancer	3.84e-06	2.39e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—liver cancer	3.83e-06	2.39e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CA—liver cancer	3.79e-06	2.37e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARG—liver cancer	3.77e-06	2.35e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP1A1—liver cancer	3.76e-06	2.35e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—KRAS—liver cancer	3.76e-06	2.34e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTM1—liver cancer	3.74e-06	2.33e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTM1—liver cancer	3.7e-06	2.31e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CA—liver cancer	3.69e-06	2.3e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—MTHFR—liver cancer	3.59e-06	2.24e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.54e-06	2.21e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP1A1—liver cancer	3.54e-06	2.21e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PSMD10—liver cancer	3.52e-06	2.2e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PSMA4—liver cancer	3.52e-06	2.2e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARA—liver cancer	3.52e-06	2.2e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP1A1—liver cancer	3.51e-06	2.19e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CD—liver cancer	3.51e-06	2.19e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—MTHFR—liver cancer	3.5e-06	2.19e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ALB—liver cancer	3.46e-06	2.16e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CA—liver cancer	3.45e-06	2.15e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTP1—liver cancer	3.44e-06	2.15e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARA—liver cancer	3.44e-06	2.15e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CD—liver cancer	3.43e-06	2.14e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GOT2—liver cancer	3.43e-06	2.14e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HMOX1—liver cancer	3.4e-06	2.12e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ALB—liver cancer	3.39e-06	2.11e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CG—liver cancer	3.38e-06	2.11e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—liver cancer	3.36e-06	2.1e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—MTHFR—liver cancer	3.3e-06	2.06e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—MTHFR—liver cancer	3.27e-06	2.04e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARG—liver cancer	3.26e-06	2.04e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARA—liver cancer	3.24e-06	2.02e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP2E1—liver cancer	3.22e-06	2.01e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CA—liver cancer	3.21e-06	2e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARA—liver cancer	3.21e-06	2e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—liver cancer	3.19e-06	1.99e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTM1—liver cancer	3.17e-06	1.98e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.16e-06	1.97e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—liver cancer	3.14e-06	1.96e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—liver cancer	3.1e-06	1.93e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CB—liver cancer	3.06e-06	1.91e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—liver cancer	3.06e-06	1.91e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CG—liver cancer	3.02e-06	1.88e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYCS—liver cancer	3.02e-06	1.88e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—liver cancer	3.01e-06	1.88e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP1A1—liver cancer	3e-06	1.87e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CB—liver cancer	2.99e-06	1.87e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CD—liver cancer	2.97e-06	1.85e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GOT1—liver cancer	2.96e-06	1.85e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GGT1—liver cancer	2.96e-06	1.85e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CG—liver cancer	2.94e-06	1.84e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ALB—liver cancer	2.93e-06	1.83e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARG—liver cancer	2.91e-06	1.82e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CA—liver cancer	2.89e-06	1.8e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.89e-06	1.8e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARG—liver cancer	2.84e-06	1.77e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—liver cancer	2.82e-06	1.76e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—MTHFR—liver cancer	2.8e-06	1.75e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CG—liver cancer	2.77e-06	1.73e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CG—liver cancer	2.75e-06	1.72e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CA—liver cancer	2.75e-06	1.71e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARA—liver cancer	2.74e-06	1.71e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARG—liver cancer	2.68e-06	1.67e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTP1—liver cancer	2.66e-06	1.66e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARG—liver cancer	2.65e-06	1.66e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CD—liver cancer	2.65e-06	1.66e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—liver cancer	2.62e-06	1.64e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HMOX1—liver cancer	2.62e-06	1.64e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALB—liver cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CB—liver cancer	2.59e-06	1.62e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CD—liver cancer	2.59e-06	1.62e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALB—liver cancer	2.56e-06	1.59e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CA—liver cancer	2.54e-06	1.59e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CA—liver cancer	2.52e-06	1.57e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.47e-06	1.54e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTM1—liver cancer	2.44e-06	1.52e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CD—liver cancer	2.44e-06	1.52e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CD—liver cancer	2.42e-06	1.51e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALB—liver cancer	2.41e-06	1.5e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALB—liver cancer	2.39e-06	1.49e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—liver cancer	2.36e-06	1.47e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CG—liver cancer	2.35e-06	1.47e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CA—liver cancer	2.35e-06	1.46e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1A1—liver cancer	2.32e-06	1.45e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CB—liver cancer	2.31e-06	1.44e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARG—liver cancer	2.27e-06	1.42e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CB—liver cancer	2.26e-06	1.41e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—liver cancer	2.24e-06	1.4e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MTHFR—liver cancer	2.16e-06	1.35e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CB—liver cancer	2.13e-06	1.33e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARA—liver cancer	2.12e-06	1.32e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CB—liver cancer	2.11e-06	1.32e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—liver cancer	2.08e-06	1.3e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CD—liver cancer	2.07e-06	1.29e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—liver cancer	2.06e-06	1.29e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALB—liver cancer	2.04e-06	1.27e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—liver cancer	1.92e-06	1.2e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CA—liver cancer	1.86e-06	1.16e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CA—liver cancer	1.82e-06	1.14e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CG—liver cancer	1.81e-06	1.13e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CB—liver cancer	1.8e-06	1.12e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARG—liver cancer	1.75e-06	1.09e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CD—liver cancer	1.59e-06	9.95e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CA—liver cancer	1.58e-06	9.85e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALB—liver cancer	1.57e-06	9.82e-06	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—liver cancer	1.52e-06	9.51e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—liver cancer	1.49e-06	9.29e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CA—liver cancer	1.41e-06	8.79e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CB—liver cancer	1.39e-06	8.67e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CA—liver cancer	1.38e-06	8.58e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CA—liver cancer	1.3e-06	8.09e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—liver cancer	1.29e-06	8.05e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CA—liver cancer	1.28e-06	8.02e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—liver cancer	1.15e-06	7.18e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—liver cancer	1.12e-06	7.01e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CA—liver cancer	1.1e-06	6.85e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—liver cancer	1.06e-06	6.61e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—liver cancer	1.05e-06	6.55e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—liver cancer	8.97e-07	5.6e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CA—liver cancer	8.47e-07	5.29e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—liver cancer	6.92e-07	4.32e-06	CbGpPWpGaD
